Baillie Gifford & CO Aduro Biotechnology Transaction History

Baillie Gifford & CO

$131 Billion
Q3 2024

Shares

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 12, 2020	SELL	N/A	-4,282,720 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	N/A	3,396 Added 0.08%	4,282,720 $9.89 Million
Q1 2020 May 08, 2020	BUY	N/A	47,068 Added 1.11%	4,279,324 $11.7 Million
Q4 2019 Feb 10, 2020	BUY	N/A	105,800 Added 2.56%	4,232,256 $5 Million
Q3 2019 Nov 07, 2019	BUY	N/A	55,732 Added 1.37%	4,126,456 $4.37 Million
Q2 2019 Aug 08, 2019	BUY	N/A	239,298 Added 6.25%	4,070,724 $6.27 Million
Q1 2019 May 01, 2019	BUY	N/A	170,253 Added 4.65%	3,831,426 $0
Q4 2018 Feb 14, 2019	BUY	N/A	584,348 Added 18.99%	3,661,173 $9.67 Million
Q3 2018 Nov 13, 2018	BUY	N/A	266,317 Added 9.48%	3,076,825 $22.6 Million
Q2 2018 Jul 17, 2018	BUY	N/A	1,153,771 Added 69.64%	2,810,508 $19.7 Million
Q1 2018 May 10, 2018	BUY	N/A	614,124 Added 58.9%	1,656,737 $15.4 Million
Q4 2017 Feb 13, 2018	BUY	N/A	489,523 Added 88.51%	1,042,613 $7.82 Million
Q3 2017 Oct 20, 2017	BUY	N/A	130,390 Added 30.85%	553,090 $5.89 Million
Q2 2017 Aug 10, 2017	BUY	N/A	422,700	422,700 $4.82 Million

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.